Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 6836-22-2 | MDL No. : | MFCD12756806 |
Formula : | C13H12O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GJPYHKXILUFWKV-UHFFFAOYSA-N |
M.W : | 216.23 | Pubchem ID : | 13570105 |
Synonyms : |
7-Methoxy-NAA
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.15 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 61.98 |
TPSA : | 46.53 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.05 cm/s |
Log Po/w (iLOGP) : | 1.84 |
Log Po/w (XLOGP3) : | 2.21 |
Log Po/w (WLOGP) : | 2.48 |
Log Po/w (MLOGP) : | 2.31 |
Log Po/w (SILICOS-IT) : | 2.7 |
Consensus Log Po/w : | 2.31 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -2.84 |
Solubility : | 0.314 mg/ml ; 0.00145 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.82 |
Solubility : | 0.326 mg/ml ; 0.00151 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.99 |
Solubility : | 0.0223 mg/ml ; 0.000103 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.39 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | Stage #1: With sodium hydroxide; water In methanol at 40℃; for 2 h; Stage #2: With hydrogenchloride In water |
Step 3 (7-Methoxy-naphthalen-1-yl)-acetic acid: Sodium hydroxide (0.62 g; 15.6 mmol) and water (6 mL) was added to a solution of (7-methoxy-naphthalen-1-yl)-acetic acid ethyl ester (2.38 g; 9.8 mmol) in methanol (12 mL). Under continuous stirring, the mixture was maintained at about 40° C. for about 2 hours. The mixture was then concentrated in vacuo, the residue was diluted with water (50 mL), and extracted with ether (4*25 mL). The aqueous phase was acidified with concentrated hydrochloric acid until a pH of 2 was achieved. Standard extractive workup afforded the title product as an off-white solid (1.9 g; 90percent yield). 1H NMR (300 MHz, CD3OD) δ 3.9 (s, 3H), 4.03 (s, 2H), 7.15 (dd, J=9.0, 2.4 Hz, 1H), 7.27-7.41 (m, 4H), 7.76 (m, 2H); LC-MS: 215 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With palladium on activated charcoal; sodium carbonate; acrylic acid In water at 100 - 105℃; | A mixture of 2-(7-methoxy-1 ,2,3,4,-tetrahydro -1 -naphthylidine) acetic acid (100gm), water(600 ml), sodium bicarbonate (100 gm), acrylic acid (49.50 g) and Pd/C (3.0 g) was heated at 100-105 ° C for 12 hrs. Reaction mixture was cooled, filtered. The mixture was partitioned between toluene and water. The aqueous phase, cooled at 10 to 15 ° C and acidified with cone. HCI. the precipitate was isolated and dried to obtain 2- (7-methoxy-1 -naphthyl) acetic acid (Yield 95 percent, HPLC purity 99percent). |